- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02894229
The Stress Reduction Intervention Study
April 3, 2018 updated by: Ohio University
The Mindfulness Intervention and Repeated Acute Stress (MIRAS) Study
The primary purpose of the present study is to investigate the relationship between mindfulness and stress habituation.
The investigators propose to measure the effect of mindfulness on stress habituation by randomly assigning participants to a 6-week mindfulness-based stress reduction group intervention, a cognitive-behavioral skills group comparison intervention, or a waitlist control condition followed by repeated acute psychosocial stress testing (2 laboratory sessions on 2 separate days).
Saliva will be collected from participants throughout both laboratory testing sessions to measure HPA axis activation (an essential stress-responsive system), along with other measures of physiological and psychological stress (e.g., heart rate, blood pressure, emotions).
Mediators and moderators of treatment outcome will be examined.
The cognitive-behavioral skills group condition is an appropriate comparison group due to the well-documented efficacy of cognitive-behavioral interventions on stress.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- English-speaking adults who are between the ages of 18-50, who are in general good health
- Perceived stress scores (PSS) > 3 on a screening survey
Exclusion Criteria:
- reported previous completion of a Mindfulness-Based Stress Reduction or Cognitive Behavioral Therapy program.
- reported pregnancy
- reported use of steroid medication
- presence of a major psychiatric or endocrine disorder (e.g., Major Depression, Cushings Disease; self-reported)
- reported regular wake time after 10:00 AM on a weekday
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: No intervention wait-list
This arm will receive no intervention for approximately the first 4 months.
At the conclusion of the 4-month period, this group will receive a 6-week cognitive-behavioral therapy (CBT) group
|
|
|
Active Comparator: Mindfulness Based Stress Reduction(MBSR)
This arm will receive 6 weekly, 2-hour groups that focuses on mindfulness meditation for stress reduction
|
A modified version of traditional MBSR.
The current study's version of MBSR is shortened to 6-weeks.
|
|
Active Comparator: Cognitive Behavioral Therapy (CBT) Group
This are will receive 6 weekly, 2-hour groups that focus on cognitive-behavioral skills for stress
|
A 6-week, 2-hour per group, skills group that focuses on various cognitive-behavioral skills for stress reduction (e.g., progressive muscle relaxation; cognitive restructuring).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perceived Stress Scale
Time Frame: Baseline and 6-weeks after baseline.
|
A 10-item self-report measure that examines perceived stress.
The measure produces one total score.
The investigators will measure the change in total score from baseline to the 6-week assessment.
|
Baseline and 6-weeks after baseline.
|
|
Salivary cortisol response to repeated acute psychosocial stress
Time Frame: Post-intervention (approximately 7-14 weeks after baseline assessment)
|
4 saliva samples will be collected before and after a psychosocial stressor task, which will be administered on two separate occasions separated in time by at least 48 hours.
All saliva samples will be assayed for salivary cortisol using enzyme-linked immunoassays.
The investigators will measure the change in cortisol stress profiles from the first stressor exposure to the second.
|
Post-intervention (approximately 7-14 weeks after baseline assessment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiovascular response to repeated acute psychosocial stress
Time Frame: Post-intervention (approximately 7-14 weeks after baseline assessment)
|
Heart rate and blood pressure will be assessed non-invasively and periodically before, during, and after non-invasively a psychosocial stressor task, with an Omron Health Care HEM-907XL Professional Blood Pressure Monitor.
The investigators will measure the change in heart rate and blood pressure stress profiles from the first stressor exposure to the second.
|
Post-intervention (approximately 7-14 weeks after baseline assessment)
|
|
Autonomic response to repeated acute psychosocial stress
Time Frame: Post-intervention (approximately 7-14 weeks after baseline assessment)
|
Heart rate variability will be assessed continuously before, during, and after non-invasively a psychosocial stressor task, with a MP150 device manufactured by BIOPAC.
The investigators will measure the change in heart rate variability stress profiles from the first stressor exposure to the second.
|
Post-intervention (approximately 7-14 weeks after baseline assessment)
|
|
Dispositional Mindfulness
Time Frame: Baseline and 6-weeks
|
Five Facet Mindfulness Questionnaire
|
Baseline and 6-weeks
|
|
Equanimity
Time Frame: Baseline and 6-weeks
|
The Non-Attachment Scale
|
Baseline and 6-weeks
|
|
Smoking
Time Frame: Baseline and 6-weeks
|
Fagerstrom Test for Nicotine Dependence
|
Baseline and 6-weeks
|
|
Alcohol
Time Frame: Baseline and 6-weeks
|
Alcohol Use Disorders Identification Test - Consumption items
|
Baseline and 6-weeks
|
|
Marijuana
Time Frame: Baseline and 6-weeks
|
Single item assessing frequency of marijuana use
|
Baseline and 6-weeks
|
|
Perceived control over thoughts
Time Frame: Baseline and 6 weeks
|
Thought Control Ability Questionnaire
|
Baseline and 6 weeks
|
|
Coping Skills
Time Frame: Baseline and 6-weeks
|
Brief-COPE measure
|
Baseline and 6-weeks
|
|
Depressed mood
Time Frame: Baseline and 6-weeks
|
Center for Epidemiologic Studies Depression Scale
|
Baseline and 6-weeks
|
|
Anxiety
Time Frame: Baseline and 6-weeks later
|
Spielberger State-Trait Anxiety Inventory
|
Baseline and 6-weeks later
|
|
Social Connectedness
Time Frame: Baseline and 6-weeks
|
Social Connectedness Scale-Revised
|
Baseline and 6-weeks
|
|
Optimism
Time Frame: Baseline and 6-weeks
|
Life Orientation Test
|
Baseline and 6-weeks
|
|
Worry
Time Frame: Baseline and 6-weeks
|
Penn State Worry Questionnaire
|
Baseline and 6-weeks
|
|
Experiential Avoidance
Time Frame: Baseline and 6-weeks
|
Acceptance and Action Questionnaire-II
|
Baseline and 6-weeks
|
|
Emotion Regulation
Time Frame: Baseline and 6-weeks
|
Difficulties in Emotion Regulation Scale
|
Baseline and 6-weeks
|
|
Negative Urgency
Time Frame: Baseline and 6-weeks
|
UPPS-P Impulsive Behavior Scale: Negative Urgency Items
|
Baseline and 6-weeks
|
|
Chronic Stress
Time Frame: Baseline and 6-weeks
|
Trier Inventory for Chronic Stress
|
Baseline and 6-weeks
|
|
Sleep
Time Frame: Baseline and 6-weeks
|
Pittsburgh Sleep Quality Index
|
Baseline and 6-weeks
|
|
State Affect
Time Frame: Post-intervention (approximately 7-14 weeks after baseline assessment)
|
Positive and Negative Affect Schedule (PANAS) will be used to assess state affect and specific emotions several times before and after a psychosocial stressor task.
The investigators will measure the change in emotion response profiles from the first stressor exposure to the second.
|
Post-intervention (approximately 7-14 weeks after baseline assessment)
|
|
State mindfulness
Time Frame: Post-intervention (approximately 7-14 weeks after baseline assessment)
|
Mindful Attention Awareness Scale (MAAS) - state version.
The investigators will measure the change in state mindfulness from the first stressor exposure to the second.
|
Post-intervention (approximately 7-14 weeks after baseline assessment)
|
|
Implicit association between self and shame
Time Frame: Post-intervention (approximately 7-14 weeks after baseline assessment)
|
A shame experience and self implicit association test will be used to measure experiential self-referential processing of present moment shame.
The investigators will measure the change in implicit association between self and shame from the first stressor exposure to the second.
|
Post-intervention (approximately 7-14 weeks after baseline assessment)
|
|
State rumination
Time Frame: Post-intervention (approximately 7-14 weeks after baseline assessment)
|
Thoughts Questionnaire (TQ).
The investigators will measure the change in state rumination from the first stressor exposure to the second.
|
Post-intervention (approximately 7-14 weeks after baseline assessment)
|
|
Stress appraisals
Time Frame: Post-intervention (approximately 7-14 weeks after baseline assessment)
|
Cognitive task appraisals will be assessed before and after a psychosocial stressor task.
The investigators will measure the change in appraisals from the first stressor exposure to the second.
|
Post-intervention (approximately 7-14 weeks after baseline assessment)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2016
Primary Completion (Anticipated)
July 1, 2019
Study Completion (Anticipated)
July 1, 2019
Study Registration Dates
First Submitted
September 5, 2016
First Submitted That Met QC Criteria
September 8, 2016
First Posted (Estimate)
September 9, 2016
Study Record Updates
Last Update Posted (Actual)
April 4, 2018
Last Update Submitted That Met QC Criteria
April 3, 2018
Last Verified
April 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16F18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress, Psychological
-
University of Thi-QarCompletedPsychological Stress | Academic StressIraq
-
Amsterdam UMC, location VUmcRigshospitalet, Denmark; Universitätsklinikum Hamburg-EppendorfNot yet recruitingStress | Stress and Burnout | Stress BiomarkersGermany, Denmark
-
New York State Psychiatric InstituteJohnson & JohnsonCompletedPsychological Stress in PregnancyUnited States
-
Hacettepe UniversityCompletedStressTurkey (Türkiye)
-
Baylor UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedAcute Psychological StressUnited States
-
Örebro University, SwedenCompletedPsychological Stress Due to SkydivingSweden
-
Universität Duisburg-EssenRecruitingStress | Burnout | Burnout Syndrome | Stress ResilienceGermany
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Amrita Vishwa VidyapeethamAmrita Viswa VidyapeethamCompletedCovid Related Psychological StressIndia
-
University of WashingtonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not yet recruitingPsychological Stress | Social Interaction
Clinical Trials on Mindfulness Based Stress Reduction
-
Duke UniversityNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Inflammation | Stress, Psychological | SleepUnited States
-
University of California, San FranciscoCompletedDementia | Frontotemporal Dementia | Frontotemporal Lobar Degeneration | Caregiver Stress Syndrome | Caregiver Burnout | Dementia Frontal | Mindfulness Based Stress ReductionUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingChronic Low-back PainUnited States
-
Oregon Health and Science UniversityPortland VA Medical CenterCompleted
-
Fatima Jinnah Women UniversityRecruitingBehavior Problem | Emotional ProblemPakistan
-
Fatima Jinnah Women UniversityNot yet recruitingPsychological StressPakistan
-
University of PaviaUniversity of Siena, ItalyCompletedWell-being | Work-Related Stress | Employees of University | Inflammation StatusItaly
-
Toronto Metropolitan UniversityCompleted
-
Saglik Bilimleri UniversitesiCompletedObesity | Polycystic Ovary Syndrome | StressTurkey
-
Medicos e Investigadores en la Lucha contra el...CompletedBreast Cancer | Anxiety | SurvivorshipMexico